Epalrestat
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Description: Epalrestat (ONO2235), an aldose reductase inhibitor, is well tolerated in Long-term... more
Product information "Epalrestat"
Description: Epalrestat (ONO2235), an aldose reductase inhibitor, is well tolerated in Long-term therapy. It can effectually ameliorate the associated symptoms of diabetic neuropathy and delay the progression of the disease, particularly in patients with limited microangiopathy and good glycemic control. Target: Reductase. Smiles: CC(=C/C1=CC=CC=C1)\C=C1/SC(=S)N(CC(O)=O)C1=O. References: Ramirez MA, et al. PharmacOthersapy. 2008 May, 28(5):646-55.
| Keywords: | ONO2235 |
| Supplier: | TargetMol |
| Supplier-Nr: | T1458 |
Properties
| Application: | Targets aldehyde reductase [EC:1.1.1.21] (AKR1B) |
| MW: | 319.4 D |
| Formula: | C15H13NO3S2 |
Database Information
| CAS : | 82159-09-9| Matching products |
| KEGG ID : | K00011 | Matching products |
Handling & Safety
| Storage: | -20°C |
| Shipping: | +4°C (International: +4°C) |
| Signal Word: | Danger |
| GHS Hazard Pictograms: |
|
| H Phrases: | H300 |
| P Phrases: | P264, P270, P321, P330, P301+P310, P405, P501 |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
Viewed